SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-003429
Filing Date
2021-07-02
Accepted
2021-07-02 17:09:13
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 form4-07022021_020752.html 4  
1 form4-07022021_020752.xml 4 12124
  Complete submission text file 0001415889-21-003429.txt   13614
Mailing Address 760 PARKSIDE AVE. SUITE 304 SUITE 207 BROOKLYN NY 11226
Business Address
Schneiderman Daniel H (Reporting) CIK: 0001565536 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 211071380

Mailing Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445
Business Address 1615 SOUTH CONGRESS AVENUE SUITE 103 DELRAY BEACH FL 33445 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations